Aíma develops advanced liquid biopsy tests for minimal residual disease and early cancer detection. Our whole-genome methylation and fragmentomics platform combines AI with ultra-sensitive sequencing to detect cancer DNA and determine its tissue of origin. We collaborate with leading clinical cente... Read more
Org chart
Collapse
Teams
This company has no teams yet
Offices
This company has no offices yet
